Haoxi Health Technology (HAO) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
10 Jan, 2026Opening remarks and agenda
CEO and Chairman welcomed shareholders and introduced the meeting, confirming adherence to the Articles of Association.
Director of Investor Relations outlined the meeting's purpose and handed over proceedings.
Shareholder proposals
Proposals included share consolidation at a 1-for-25 ratio, increase of authorized share capital, amendments to the Memorandum and Articles of Association, re-election of five directors, ratification and appointment of auditors for 2024 and 2025, and authorization to adjourn the 2025 AGM if needed.
Corporate governance
Notice of the meeting was distributed to shareholders on or around December 19, 2024, and all required documents were available for inspection.
Inspector of elections was appointed and quorum was confirmed with more than one-third of shares represented.
Latest events from Haoxi Health Technology
- Registering up to $80M in securities, with strong revenue growth and high PRC regulatory risk.HAO
Registration Filing16 Dec 2025 - Raising up to $80M on Nasdaq, the company targets healthcare marketing in China amid regulatory risks.HAO
Registration Filing16 Dec 2025 - FY2025 revenue fell 32% while net income surged to $3.88M, with ongoing regulatory and supplier risks.HAO
Q4 202412 Dec 2025 - Raising $9.09M to expand healthcare-focused digital marketing in China, but faces regulatory and concentration risks.HAO
Registration Filing29 Nov 2025 - IPO funds will drive growth and tech investment, but regulatory and supplier risks remain high.HAO
Registration Filing29 Nov 2025 - Chinese healthcare-focused ad tech firm seeks $11.4M via Nasdaq unit offering, CEO retains control.HAO
Registration Filing29 Nov 2025 - Offering 2,093,802 units at $5.97 each, the company targets healthcare ads but faces regulatory and concentration risks.HAO
Registration Filing29 Nov 2025 - Rapid revenue growth, high regulatory risk, and CEO control define this complex offering.HAO
Registration Filing29 Nov 2025 - Rapid revenue growth, but high supplier concentration and regulatory risks; $11.4M IPO with warrants.HAO
Registration Filing29 Nov 2025